PharmaDrug Engages Research Lab To Advance Patented Cocaine Synthesis Method
PharmaDrug (CSE: PHRX) has formally engaged a research lab to refine and advance the development of its patented cocaine synthesis process.
Read morePharmaDrug (CSE: PHRX) has formally engaged a research lab to refine and advance the development of its patented cocaine synthesis process.
Read morePharmaDrug Inc (CSE: PHRX) last month revealed that it has begun work on developing a novel manufacturing method for a biosynthetic pharmaceutical grade cocaine, which is intended to be used to support safe supply programs being put into place around the globe.
Read moreSwitzerland is currently reevaluating its stance on drug policy as reports emerge of a groundbreaking proposal to legalize the sale of cocaine for recreational use in the capital city of Bern. This comes in response to mounting evidence suggesting that the country’s longstanding “war on drugs” has proven ineffective.
Read moreIn this interview, David Kideckel, CEO of PharmaDrug (CSE: PHRX), discusses the company’s groundbreaking biosynthetic manufacturing method for pharmaceutical-grade cocaine for safe supply.
Read morePharmaDrug’s (CSE: PHRX) subsidiary SecureDose has finally revealed its first biosynthetic formulation: pharmaceutical grade cocaine.
Read morePharmaDrug (CSE: PHRX) this morning released a series of updates, headlined by the appointment of Dr David Kideckel to the role of Chairman of the company, who previously served as a director of the firm.
Read morePharmaDrug (CSE: PHRX) has seen its joint venture with PharmaTher Holdings (CSE: PHRM) begin to bear fruit. The venture, referred to as Sairiyo Therapeutics, has seen a milestone in the development of Cepharanthine, also known as PD-001.
Read moreThe United States is grappling with a relentless surge in fentanyl-related overdose deaths, marking a grim chapter in the ongoing battle against opioid addiction. As the fourth wave of the opioid epidemic crashes through communities nationwide, the devastating toll of fentanyl misuse has left families shattered and communities reeling.
Read moreKhiron Life Sciences Corp. (TSXV: KHRN) announced today the plan to acquire Pharmadrug GmbH, a German cannabis subsidiary of PharmaDrug
Read moreIt appears that Red Light Holland (CSE: TRIP) and Pharmadrug Inc (CSE: BUZZ) have entered into a securities exchange agreement
Read more